Well, hello, hello, guys. You're listening to Beauty Bites with Dr. K.A. Secrets of a Plastic

Surgeon. And today on the podcast, I'm very excited to introduce you guys to a really revolutionary brand

new technology. We're going to interview Yehiel Tal. He's the chief executive officer of

Cal Plant. And this is a pioneering biotech company. They specialize in regenerative medicine

and 3D bioprinting technology. So he has a strong background in innovation and leadership,

and they are developing plant-based recombinant human collagen and cutting-edge solutions to

tissue engineering, organ printing. And this is a really cutting-edge field. We are going to learn today about these new initiatives.

He's driving in aesthetics, orthopedics, and 3D bioprinting applications.

He brings years of engineering to this experience, and I'm so excited to learn about plant-based human recombinant collagen and potentially the implants and things that you're creating.

So welcome, Youheel, to the podcast.

Thank you for having me.

Wonderful. So tell us a little bit about your background.

Are you an engineer by training? How did you get into the medical aspect of engineering?

Yeah, my background in training is mechanical engineering.

My degrees are mechanical engineering from the Technion in Israel, which is the Technological

Institute.

And then I worked 17 years in the semiconductor area.

I was stationed part of the time in the Bay Area in Silicon Valley. And then in the year 2004, I founded my first company in the field of regenerative medicine,

which was companies that developed cartilage implants, injectable implants,

for the joint cartilage. and then six years later I joined

Kohl-Klund.

And you guys have now developed a plant-based recombinant human collagen. Can you explain?

...